关节痛注射液市场 - 增长、趋势、COVID-19 影响和预测(2022 - 2027 年)

关节疼痛注射市场市场按注射类型、应用(肩部和肘部、膝部和踝部、脊柱关节、髋关节等)和地理划分

市场快照

Joint Pain Injections Market Size
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 6 %
Joint Pain Injections Market Major Players

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

关节炎和肌肉骨骼疾病患病率的上升推动了对关节疼痛注射使用的需求,特别是在 65 岁或以上的人群中,因为他们更容易出现关节疼痛。

根据名为“2018 年肌肉骨骼健康状况”的英国关节炎研究报告,估计英国有 1780 万人患有肌肉骨骼疾病。约占总人口的28.9%。由于口服药物不能缓解关节疼痛,并且大多数患者对进行手术不感兴趣,因此关节疼痛注射是最理想的程序。

然而,对这些注射剂缺乏认识以及产品的高成本可能会阻碍市场的增长。

报告范围

根据报告的范围,关节疼痛注射剂是可以直接注射到膝关节或身体任何关节的产品,以帮助快速缓解膝关节疼痛和炎症。对于全身抗炎或镇痛药物反应不足或有禁忌症的患者,首选关节痛注射液。

Type of Injection
Steroid Joint Injections
Hyaluronic Acid Injections
Platelet-rich Plasma (PRP) Injections
Placental Tissue Matrix (PTM) Injections
Others
Applications
Shoulder & Elbow
Knee & Ankle
Spinal Joints
Hip Joint
Others
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

主要市场趋势

类固醇联合注射剂市场占有率显着

类固醇关节疼痛注射是一种微创手术,可以暂时缓解关节炎症引起的疼痛。类固醇关节疼痛注射剂包含皮质类固醇和麻醉麻木剂,例如利多卡因或布比卡因。药物被输送到关节囊内的疼痛关节。

因此,类固醇注射可以减少炎症,并且在直接注射到疼痛区域时是有效的。好处可以持续几个月。市场主体广泛专注于开发具有诸多优势的新奇产品,并频频推出产品。

Joint Pain Injections Market Share

北美有望在关节痛注射剂市场占有最大的市场份额

由于导致关节疼痛的肌肉骨骼疾病的高发率,预计北美将主导市场。提高对非侵入性骨科治疗的认识、植入技术的不断创新以及先进的医疗保健设施。 

根据疾病控制和预防中心 (CDC) 的说法,关节炎引起的慢性疼痛每年影响着美国数百万人。大约四分之一的患有关节炎的成年人,有 1500 万人报告经历了与关节炎相关的严重关节疼痛。先进技术的高采用率也是推动该地区市场增长的因素。此外,主要市场参与者正在对研究活动进行巨额投资,最终将推动北美市场。

Joint Pain Injections Market Growth

竞争格局

全球关节痛注射剂市场是一个适度分散的市场。市场参与者专注于持续的产品开发和以具有竞争力的价格提供关节疼痛注射剂,尤其是在发展中国家。

市场的主要发展包括:2017 年 2 月,Zimmer Biomet 的 Gel-One Hyaluronate a 透明质酸注射液获得美国 FDA 批准,用于治疗膝骨关节炎患者 26 周;2018 年 5 月,Teva Pharmaceuticals USA, Inc. 获得美国 FDA 批准SYNOJOYNT 作为膝关节骨关节炎患者的止痛药。

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Growing Prevalence of Arthritis and Increasing Geriatric Population Worldwide

      2. 4.2.2 Increasing Demand for Knee Pain Injections

    3. 4.3 Market Restraints

      1. 4.3.1 High Costs of the Injections

      2. 4.3.2 Reimbursement Issues

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 Type of Injection

      1. 5.1.1 Steroid Joint Injections

      2. 5.1.2 Hyaluronic Acid Injections

      3. 5.1.3 Platelet-rich Plasma (PRP) Injections

      4. 5.1.4 Placental Tissue Matrix (PTM) Injections

      5. 5.1.5 Others

    2. 5.2 Applications

      1. 5.2.1 Shoulder & Elbow

      2. 5.2.2 Knee & Ankle

      3. 5.2.3 Spinal Joints

      4. 5.2.4 Hip Joint

      5. 5.2.5 Others

    3. 5.3 Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States

        2. 5.3.1.2 Canada

        3. 5.3.1.3 Mexico

      2. 5.3.2 Europe

        1. 5.3.2.1 Germany

        2. 5.3.2.2 United Kingdom

        3. 5.3.2.3 France

        4. 5.3.2.4 Italy

        5. 5.3.2.5 Spain

        6. 5.3.2.6 Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. 5.3.3.1 China

        2. 5.3.3.2 Japan

        3. 5.3.3.3 India

        4. 5.3.3.4 Australia

        5. 5.3.3.5 South Korea

        6. 5.3.3.6 Rest of Asia-Pacific

      4. 5.3.4 Middle-East and Africa

        1. 5.3.4.1 GCC

        2. 5.3.4.2 South Africa

        3. 5.3.4.3 Rest of Middle-East and Africa

      5. 5.3.5 South America

        1. 5.3.5.1 Brazil

        2. 5.3.5.2 Argentina

        3. 5.3.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Anika Therapeutics, Inc.

      2. 6.1.2 Bioventus.

      3. 6.1.3 Ferring Pharmaceuticals Inc.

      4. 6.1.4 Sanofi S.A.

      5. 6.1.5 Pfizer Inc.

      6. 6.1.6 Eli Lilly and Company

      7. 6.1.7 Flexion Therapeutics, Inc.

      8. 6.1.8 Teva Pharmaceuticals

      9. 6.1.9 Zimmer Biomet

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Joint Pain Injections Market market is studied from 2018 - 2026.

The Joint Pain Injections Market is growing at a CAGR of 6% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Anika Therapeutics, Inc., Bioventus, Ferring Pharmaceuticals Inc., Sanofi, Zimmer Biomet are the major companies operating in Joint Pain Injections Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!